#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
EN
proLékaře.cz / Odborné časopisy / Česko-slovenská pediatrie / 2016 - 1

Literatura

Stáhnout PDF

Vyšlo v časopise: Čes-slov Pediat 2016; 71 (1): 39-43.
Kategorie: Doporučené postupy

  1. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49 : 498–547.
  2. Lightdale JR, Gremse DA. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 2013; 131: e1684–e1695.
  3. Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360 : 1487–1499.
  4. Blake K, Teague WG. Gastroesophageal reflux disease and childhood asthma. Curr Opin Pulm Med 2013; 19 : 24–29.
  5. Ghezzi M, Silvestri M, Guida E, et al. Acid and weakly acid gastroesophageal refluxes and type of respiratory symptoms in children. Respir Med 2011; 105 : 972–978.
  6. Piccione JC, McPhail GL, Fenchel MC, et al. Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications. Pediatr Pulmonol 2012; 47 : 447–452.
  7. Khoshoo V, Mohnot S, Haydel R Jr, et al. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment. Pediatr Pulmonol 2009; 44 : 1070–1074.
  8. Rothenberg S, Cowles R. The effects of laparoscopic Nissen fundoplication on patients with severe gastroesophageal reflux disease and steroid-dependent asthma. J Pediatr Surg 2012; 47 : 1101–1104.
  9. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and behavioral pain measures in children aged 3-7 years after surgery. J Pain Symptom Manage 1990; 5 : 350–356.
  10. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101 : 1–78.
  11. Ossakow SJ, Elta G, Colturi T, et al. Esophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann Otol Rhinol Laryngol 1987; 96 : 387–392.
  12. Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989; 84 : 1503–1508.
  13. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111 : 1313–1317.
  14. Belafsky PC, Postma GN, Amin MR, et al. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J 2002; 81 : 10–13.
  15. Ylitalo R, Baugh A, Li W, et al. Effect of acid and pepsin on gene expression in laryngeal fibroblasts. Ann Otol Rhinol Laryngol 2004; 113 : 866–871.
  16. Del Buono R, Wenzl TG, Rawat D, et al. Acid and nonacid gastro-oesophageal reflux in neurologically impaired children: investigation with the multiple intraluminal impedance procedure. J Pediatr Gastroenterol Nutr 2006; 43 : 331–335.
  17. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol 2003; 112 : 481–491.
  18. Koufman JA. Laryngopharyngeal reflux 2002: a new paradigm of airway disease. Ear Nose Throat J 2002; 81 : 2–6.
  19. Little FB, Koufman JA, Kohut RI, et al. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985; 94 : 516–519.
  20. Postma GN, Belafsky PC, Aviv JE, et al. Laryngopharyngeal reflux testing. Ear Nose Throat J 2002; 81 : 14–18.
  21. Smit CF, van Leeuwen JA, Mathus-Vliegen LM, et al. Gastropharyngeal and gastroesophageal reflux in globus and hoarseness. Arch Otolaryngol Head Neck Surg 2000; 126 : 827–830.
  22. Vincent DA, Jr., Garrett JD, Radionoff SL, et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000; 14 : 247–254.
  23. Smit CF, Tan J, Devriese PP, et al. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998; 108 : 299–302.
  24. Quitadamo P, Di Nardo G, Miele E, et al. Gastro-esophageal reflux in young children and adolescents: Is there a relationship between symptom severity and esophageal histological grade? J Pediatr Gastroenterol Nutr 2015; 60 : 318–321.
  25. Corrado G, Fossati C, Turchetti A, et al. Irritable oesophagus: a new cause of Sandifer‘s syndrome. Acta Paediatr 2006; 95 : 1509–1510.
  26. Frankel EA, Shalaby TM, Orenstein SR. Sandifer syndrome posturing: relation to abdominal wall contractions, gastroesophageal reflux, and fundoplication. Dig Dis Sci 2006; 51 : 635–640.
  27. Cerimagic D, Ivkic G, Bilic E. Neuroanatomical basis of Sandifer‘s syndrome: a new vagal reflex? Med Hypotheses 2008; 70 : 957–961.
  28. Puntis JW, Smith HL, Buick RG, et al. Effect of dystonic movements on oesophageal peristalsis in Sandifer‘s syndrome. Arch Dis Child 1989; 64 : 1311–1313.
  29. Tipnis NA, Tipnis SM. Controversies in the treatment of gastroesophageal reflux disease in preterm infants. Clin Perinatol 2009; 36 : 153–164.
  30. Birch JL, Newell SJ. Gastrooesophageal reflux disease in preterm infants: current management and diagnostic dilemmas. Arch Dis Child Fetal Neonatal Ed 2009; 94: F379–83.
  31. van der Pol R, Smite M, Benninga MA, et al. Non-pharmacological therapies for GERD in infants and children. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S6–8.
  32. van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr 2007; 151 : 585-90, 90 e1–2.
  33. Fennerty MB. Use of antisecretory agents as a trial of therapy. Gut 2002; 50 (Suppl 4): iv63–66.
  34. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115 : 42–49.
  35. Wenzl TG, Benninga MA, Loots CM, et al. Indications, methodology, and interpretation of combined esophageal impedance-pH monitoring in children: ESPGHAN EURO-PIG standard protocol. J Pediatr Gastroenterol Nutr 2012; 55 : 230–234.
  36. Pilic D, Frohlich T, Noh F, et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. J Pediatr 2011; 158 : 650–654 e1.
  37. Vandenplas Y. Management of paediatric GERD. Nat Rev Gastroenterol Hepatol 2014; 11 : 147–157.
  38. Vandenplas Y, Goyvaerts H, Helven R, et al. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88 : 834–840.
  39. Wenzl TG, Moroder C, Trachterna M, et al. Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2002; 34 : 519–523.
  40. Wenzl TG. Role of diagnostic tests in GERD. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S4–6.
  41. Turk H, Hauser B, Brecelj J, et al. Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children. World J Pediatr 2013; 9 : 36–41.
  42. Hassall E. Uses and abuses of acid-suppression therapy in children. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S8–9.
  43. Blondeau K, Mertens V, Dupont L, et al. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings. Pediatr Pulmonol 2011; 46 : 286–294.
  44. Farre R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 2011; 60 : 885–892.
  45. Ummarino D, Salvatore S, Hauser B, et al. Baseline esophageal impedance according to different time intervals. Dis Esophagus 2013; 26 : 582–526.
  46. Salvatore S, Salvatoni A, Van Steen K, et al. Behind the (impedance) baseline in children. Dis Esophagus 2014; 27 : 726–731.
  47. Corvaglia L, Zama D, Gualdi S, et al. Gastro-oesophageal reflux increases the number of apnoeas in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94: F188–192.
  48. Gullung JL, Hill EG, Castell DO, et al. Oropharyngeal and esophageal swallowing impairments: their association and the predictive value of the modified barium swallow impairment profile and combined multichannel intraluminal impedance-esophageal manometry. Ann Otol Rhinol Laryngol 2012; 121 : 738–745.
  49. Strobel CT, Byrne WJ, Ament ME, et al. Correlation of esophageal lengths in children with height: application to the Tuttle test without prior esophageal manometry. J Pediatr 1979; 94 : 81–84.
  50. Pilic D, Hofs C, Weitmann S, et al. Inter -⁠ and intraobserver agreement in 24-hour combined multiple intraluminal impedance and pH measurement in children. J Pediatr Gastroenterol Nutr 2011; 53 : 255–259.
  51. Loots CM, van Wijk MP, Blondeau K, et al. Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis. J Pediatr 2012; 160 : 441–446 e1.
  52. Omari TI, Schwarzer A, vanWijk MP, et al. Optimisation of the reflux-symptom association statistics for use in infants being investigated by 24-hour pH impedance. J Pediatr Gastroenterol Nutr 2011; 52 : 408–413.
  53. Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107 : 1741–1745.
  54. Katra R, Kabelka Z, Jurovcik M, et al. Pilot study: Association between Helicobacter pylori in adenoid hyperplasia and reflux episodes detected by multiple intraluminal impedance in children. Int J Pediatr Otorhinolaryngol 2014; 78 : 1243–1249.
  55. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100 : 190–200.
  56. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005; 146: S3–12.
  57. Kahrilas PJ, Pandolfino JE. Review article: oesophageal pH monitoring –⁠ technologies, interpretation and correlation with clinical outcomes. Aliment Pharmacol Ther 2005; 22 (Suppl 3): 2–9.
  58. Lichtenstein DR, Cash BD, Davila R, et al. Role of endoscopy in the management of GERD. Gastrointest Endosc 2007; 66 : 219–224.
  59. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101 : 1900–1920; quiz 43.
  60. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40 : 275–285.
  61. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009; 104 : 1278–1295; quiz 96.
  62. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002; 109 : 1061–1067.
  63. Sharaf RN, Shergill AK, Odze RD, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013; 78 : 216–224.
  64. Jeurnink SM, van Herwaarden-Lindeboom MY, Siersema PD, et al. Barrett‘s esophagus in children: does it need more attention? Dig Liver Dis 2011; 43 : 682–687.
  65. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45 : 172–180.
  66. Armstrong D, Emde C, Inauen W, et al. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? Hepatogastroenterology 1992; 39 (Suppl 1): 3–13.
  67. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999; 72 : 93–100.
  68. Rosen R, Amirault J, Johnston N, et al. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol 2014; 49 : 1090–1096.
  69. Najada AS, Dahabreh MM. Bronchoscopy findings in children with recurrent and chronic stridor. J Bronchology Interv Pulmonol 2011; 18 : 42–47.
  70. Bibi H, Khvolis E, Shoseyov D, et al. The prevalence of gastroesophageal reflux in children with tracheomalacia and laryngomalacia. Chest 2001; 119 : 409–413.
  71. Carr MM, Nagy ML, Pizzuto MP, et al. Correlation of findings at direct laryngoscopy and bronchoscopy with gastroesophageal reflux disease in children: a prospective study. Arch Otolaryngol Head Neck Surg 2001; 127 : 369–374.
  72. Ahrens P, Noll C, Kitz R, et al. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr Pulmonol 1999; 28 : 83–88.
  73. Rosen R, Fritz J, Nurko A, et al. Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Pediatrics 2008; 121: e879–884.
  74. Kelly EA, Parakininkas DE, Werlin SL, et al. Prevalence of pediatric aspiration-associated extraesophageal reflux disease. JAMA Otolaryngol Head Neck Surg 2013; 139 : 996–1001.
  75. Farrell S, McMaster C, Gibson D, et al. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J Pediatr Surg 2006; 41 : 289–293.
  76. Starosta V, Kitz R, Hartl D, et al. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease. Chest 2007; 132 : 1557–1564.
  77. McNally P, Ervine E, Shields MD, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations. Thorax 2011; 66 : 140–143.
  78. Rosen R, Johnston N, Hart K, et al. The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Neurogastroenterol Motil 2012; 24 : 129–133, e84–85.
  79. Lommatzsch SE, Martin RJ, Good JT Jr. Importance of fiberoptic bronchoscopy in identifying asthma phenotypes to direct personalized therapy. Curr Opin Pulm Med 2013; 19 : 42–48.
  80. Sacco O, Silvestri M, Sabatini F, et al. IL-8 and airway neutrophilia in children with gastroesophageal reflux and asthma-like symptoms. Respir Med 2006; 100 : 307–315.
  81. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16 : 274–277.
  82. Stephen TC, Younoszai MK, Massey MP, et al. Diagnosis of gastroesophageal reflux in pediatrics. J Ky Med Assoc 1994; 92 : 188–191.
  83. Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. AJR Am J Roentgenol 1994; 162 : 621–626.
  84. Gupta JP, Kumar A, Jain AK, et al. Gastro-esophageal reflux disease (GERD): an appraisal of different tests for diagnosis. J Assoc Physicians India 1990; 38 (Suppl 1): 699–702.
  85. Chen MY, Ott DJ, Sinclair JW, et al. Gastroesophageal reflux disease: correlation of esophageal pH testing and radiographic findings. Radiology 1992; 185 : 483–486.
  86. Seibert JJ, Byrne WJ, Euler AR, et al. Gastroesophageal reflux -⁠ the acid test: scintigraphy or the pH probe? AJR Am J Roentgenol 1983; 140 : 1087–1090.
  87. Arasu TS, Wyllie R, Fitzgerald JF, et al. Gastroesophageal reflux in infants and children comparative accuracy of diagnostic methods. J Pediatr 1980; 96 : 798–803.
  88. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135 : 1383–1391, 91 e1–5.
  89. Kawahara H, Dent J, Davidson G. Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology 1997; 113 : 399–408.
  90. Mattioli G, Sacco O, Repetto P, et al. Necessity for surgery in children with gastrooesophageal reflux and supraoesophageal symptoms. Eur J Pediatr Surg 2004; 14 : 7–13.
  91. Saritas Yuksel E, Hong SK, Strugala V, et al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope 2012; 122 : 1312–1316.
  92. Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut 2015; 64 : 373–380.
  93. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013; 15 : 119–131.
  94. Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012; 307 : 373–381.
  95. Hassall E, Owen D, Kerr W, et al. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther 2011; 33 : 829–836.
  96. Tjon JA, Pe M, Soscia J, et al. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy 2013; 33 : 956–971.
  97. Beall DP, Henslee HB, Webb HR, et al. Milk-alkali syndrome: a historical review and description of the modern version of the syndrome. Am J Med Sci 2006; 331 : 233–242.
  98. Maclennan S, Augood C, Cash-Gibson L, et al. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2010; CD002300.
  99. Pritchard TS. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005; 59 : 725–729.
  100. Tighe MP, Afzal NA, Bevan, A et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009; 11 : 185–202.
  101. Perrio M, Voss S, Shakir SA. Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf 2007; 30 : 333–346.
  102. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52 : 464–470.
  103. Poynard T, Vernisse B, Agostini H. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux. Aliment Pharmacol Ther 1998; 12 : 159–165.
  104. Greally P, Hampton FJ, MacFadyen UM, et al. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux. Arch Dis Child 1992; 67 : 618–621.
  105. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146 : 156–158.
  106. Forbes D, Hodgson M, Hill R. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr 1986; 5 : 556–559.
  107. Tighe M, Afzal NA, Bevan A, et al. Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev 2014; 11: CD008550.
  108. Arguelles-Martin F, Gonzalez-Fernandez F, Gentles MG. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children. Am J Med 1989; 86 : 73–76.
  109. van der Pol R, Smite M, Benninga MA, et al. Non-pharmacological therapies for GERD in infants and children. J Pediatr Gastroenterol Nutr 53 (Suppl 2): S6–8.
  110. Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008; 122: e1268–1277.
  111. Salvatore S, Vandenplas Y. Gastroesophageal reflux and cow milk allergy: is there a link? Pediatrics 2002; 110 : 972–984.
  112. Alaswad B, Toubas PL, Grunow JE. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events. J Okla State Med Assoc 1996; 89 : 233–237.
  113. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354 : 2340–2348.
  114. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57 : 173–180.
  115. Piesman M, Hwang I, Maydonovitch C, et al. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol 2007; 102 : 2128–2134.
  116. Antunes EB, Lunet N. Effects of the head lift exercise on the swallow function: a systematic review. Gerodontology 2012; 29 : 247–257.
  117. Carvalho de Miranda Chaves R, Suesada M, Polisel F, et al. Respiratory physiotherapy can increase lower esophageal sphincter pressure in GERD patients. Respir Med 106 : 1794–1799.
  118. Šnajdauf J, Škába R. Dětská chirurgie. Praha: Galén; 2005.
  119. Pearson EG, Downey EC, Barnhart DC, et al. Reflux esophageal stricture--a review of 30 years‘ experience in children. J Pediatr Surg 2010; 45 : 2356–2360.
  120. Struijs MC, Lasko D, Somme S, et al. Gastric emptying scans: unnecessary preoperative testing for fundoplications? J Pediatr Surg 2010; 45 : 350–354; discussion 4.
  121. Guner YS, Elliott S, Marr CC, et al. Anterior fundoplication at the time of congenital diaphragmatic hernia repair. Pediatr Surg Int 2009; 25 : 715–718.
  122. Tannuri AC, Tannuri U, Mathias AL, et al. Gastroesophageal reflux disease in children: efficacy of Nissen fundoplication in treating digestive and respiratory symptoms. Experience of a single center. Dis Esophagus 2008; 21 : 746–750.
  123. Mauritz FA, Blomberg BA, Stellato RK, et al. Complete versus partial fundoplication in children with gastroesophageal reflux disease: results of a systematic review and meta-analysis. J Gastrointest Surg 2013; 17 : 1883–1892.
  124. Viswanath N, Wong D, Channappa D, et al. Is prophylactic fundoplication necessary in neurologically impaired children? Eur J Pediatr Surg 2010; 20 : 226–229.
  125. Kane TD. Laparoscopic Nissen fundoplication. Minerva Chir 2009; 64 : 147–157.
  126. Diaz DM, Gibbons TE, Heiss K, et al. Antireflux surgery outcomes in pediatric gastroesophageal reflux disease. Am J Gastroenterol 2005; 100 : 1844–1852.
  127. Pacilli M, Eaton S, McHoney M, et al. Four year follow-up of a randomised controlled trial comparing open and laparoscopic Nissen fundoplication in children. Arch Dis Child 2014; 99 : 516–521.
  128. Martin K, Deshaies C, Emil S. Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature. Can J Gastroenterol Hepatol 2014; 28 : 97–102.
  129. Lopez-Fernandez S, Hernandez F, Hernandez-Martin S, et al. Failed Nissen fundoplication in children: causes and management. Eur J Pediatr Surg 2014; 24 : 79–82.
  130. Gilger MA, Yeh C, Chiang J, et al. Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol 2004; 2 : 978–984.
  131. Kubiak R, Spitz L, Kiely EM, et al. Effectiveness of fundoplication in early infancy. J Pediatr Surg 1999; 34 : 295–299.
  132. Mauritz FA, van Herwaarden-Lindeboom MY, Zwaveling S, et al. Laparoscopic Thal fundoplication in children: a prospective 10 -⁠ to 15-year follow-up study. Ann Surg 2014; 259 : 388–393.
  133. Randolph JG. Y-U advancement pyloroplasty. Ann Surg 1975; 181 : 586–590.
  134. van der Zee DC, Arends NJ, Bax NM. The value of 24-h pH study in evaluating the results of laparoscopic antireflux surgery in children. Surg Endosc 1999; 13 : 918–921.
  135. Sullivan PB. Gastrointestinal disorders in children with neurodevelopmental disabilities. Dev Disabil Res Rev 2008; 14 : 128–136.
  136. Wesley JR, Coran AG, Sarahan TM, et al. The need for evaluation of gastroesophageal reflux in brain-damaged children referred for feeding gastrostomy. J Pediatr Surg 1981; 16 : 866–871.
  137. Reyes AL, Cash AJ, Green SH, et al. Gastrooesophageal reflux in children with cerebral palsy. Child: Care, Health & Development 1993; 19 : 109–118.
  138. Gustafsson PM, Tibbling L. Gastro-oesophageal reflux and oesophageal dysfunction in children and adolescents with brain damage. Acta Paediatr 1994; 83 : 1081–1085.
  139. Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain Dev 1999; 21 : 307–11.
  140. Macchini F, Leva E, Torricelli M, et al. Treating acid reflux disease in patients with Down syndrome: pharmacological and physiological approaches. Clin Exp Gastroenterol 2011; 4 : 19–22.
  141. Luzzani S, Macchini F, Valadè A, et al. Gastroesophageal reflux and Cornelia de Lange syndrome: Typical and atypical symptoms. Am J Med Genet Part A 2003; 119A: 283–287.
  142. Staiano A, Cucchiara S, Del Giudice E, et al. Disorders of oesophageal motility in children with psychomotor retardation and gastro-oesophageal reflux. Eur J Pediatr 1991; 150 : 638–641.
  143. Pensabene L, Miele E, Giudice ED, et al. Mechanisms of gastroesophageal reflux in children with sequelae of birth asphyxia. Brain Dev 2008; 30 : 563–571.
  144. Halpern LM, Jolley SG, Johnson DG. Gastroesophageal reflux: A significant association with central nervous system disease in children. J Pediatr Surg 1991; 26 : 171–183.
  145. Harrington JW, Brand DA, Edwards KS. Seizure disorder as a risk factor for gastroesophageal reflux in children with neurodevelopmental disabilities. Clinical Pediatrics 2004; 43 : 557–562.
  146. Böhmer C, Niezen-de Boer M, Klinkenberg-Knol E, et al. Gastro-oesophageal reflux disease in institutionalised intellectually disabled individuals. Neth J Med 1997; 51 : 134–139.
  147. Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer RC, et al. The prevalence of gastroesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals. Eur J Gastroenterol Hepatol 1997; 9 : 187–190.
  148. Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, et al. Gastroesophageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable? Am J Gastroenterol 2000; 95 : 1868–1872.
  149. Böhmer C, Niezen-de Boer M, Klinkenberg-Knol E, et al. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals. Am J Gastroenterol 1999; 94 : 804–810.
  150. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49 : 498–547.
  151. Gössler A, Schalamon J, Huber-Zeyringer A, et al. Gastroesophageal reflux and behavior in neurologically impaired children. J Pediatr Surg 2007; 42 : 1486–1490.
  152. Coghlan JA, Forbes A, Bell SN, et al. Efficacy and safety of a subacromial continuous ropivacaine infusion for post-operative pain management following arthroscopic rotator cuff surgery: a protocol for a randomised double-blind placebo-controlled trial. BMC Musculoskelet Disord 2008; 9 : 56.
  153. Richards C, Andrews P, Spitz L, et al. Nissen fundoplication may induce gastric myoelectrical disturbance in children. J Pediatr Surg 1998; 33 : 1801–1805.
  154. Burd RS, Price MR, Whalen TV. The role of protective antireflux procedures in neurologically impaired children: a decision analysis. J Pediatr Surg 2002; 37 : 500–506.
  155. Vernon-Roberts A, Sullivan P. Fundoplication versus post-operative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy. Cochrane Database Syst Rev 2007; CD006151.
  156. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007; 150 : 262–267. e1.
  157. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000; 137 : 800–807.
  158. Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993; 123 : 148–154.
  159. Kawai M, Kawahara H, Hirayama S, et al. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2004; 38 : 317–323.
  160. Wales PW, Diamond IR, Dutta S, et al. Fundoplication and gastrostomy versus image-guided gastrojejunal tube for enteral feeding in neurologically impaired children with gastroesophageal reflux. J Pediatr Surg 2002; 37 : 407–412.
  161. Michaud L, Coopman S, Guimber D, et al. Percutaneous gastrojejunostomy in children: efficacy and safety. Arch Dis Child 2012; 97 : 733–734.
  162. Pearl R, Robie D, Ein S, et al. Complications of gastroesophageal antireflux surgery in neurologically impaired versus neurologically normal children. J Pediatr Surg 1990; 25 : 1169–1173.
  163. Goldin AB, Sawin R, Seidel KD, et al. Do antireflux operations decrease the rate of reflux-related hospitalizations in children? Pediatrics 2006; 118 : 2326–2333.
  164. Blondeau K, Mertens V, Vanaudenaerde BA, et al. Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant 2009; 28 : 141–148.
  165. Smith C, Othersen Jr HB, Gogan NJ, et al. Nissen fundoplication in children with profound neurologic disability. High risks and unmet goals. Ann Surg 1992; 215 : 654.
  166. Koivusalo A, Pakarinen MP, Rintala RJ. The cumulative incidence of significant gastrooesophageal reflux in patients with oesophageal atresia with a distal fistula--a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg 2007; 42 : 370–374.
  167. Mathei J, Coosemans W, Nafteux P, et al. Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients. Surg Endosc 2008; 22 : 1054–1059.
  168. Esposito C, Van Der Zee D, Settimi A, et al. Risks and benefits of surgical management of gastroesophageal reflux in neurologically impaired children. Surgical Endoscopy and Other Interventional Techniques 2003; 17 : 708–710.
  169. Kawahara H, Nakajima K, Yagi M, et al. Mechanisms responsible for recurrent gastroesophageal reflux in neurologically impaired children who underwent laparoscopic Nissen fundoplication. Surgical Endoscopy and Other Interventional Techniques 2002; 16 : 767–771.
  170. Kawahara H, Okuyama H, Kubota A, et al. Can laparoscopic antireflux surgery improve the quality of life in children with neurologic and neuromuscular handicaps? J Pediatr Surg 2004; 39 : 1761–1764.
  171. Lall A, Morabito A, Dall‘Oglio L, et al. Total oesophagogastric dissociation: experience in 2 centres. J Pediatr Surg 2006; 41 : 342–346.
  172. Esposito C, Settimi A, Centonze A, et al. Laparoscopic-assisted jejunostomy. Surgical Endoscopy and Other Interventional Techniques 2005; 19 : 501–504.
  173. Harding SM, Allen JE, Blumin JH, et al. Respiratory manifesta-tions of gastroesophageal reflux disease. Ann N Y Acad Sci 2013; 1300 : 43–52.
  174. Scott RB, O‘Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 1985; 106 : 223–227.
  175. Akinola E, Rosenkrantz TS, Pappagallo M, et al. Gastroesophageal reflux in infants <32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol 2004; 21 : 57–62.
  176. Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest 2006; 129 : 260S–283S.
  177. Hershcovici T, Jha LK, Johnson T, et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011; 34 : 1295–305.
Štítky
Neonatologie Pediatrie Praktické lékařství pro děti a dorost
Článek Příznaky refluxního onemocnění v ORL oblasti
Článek Sandiferův syndrom (synonymum Sandifer-Sutcliffe syndrom)
Článek Refluxní onemocnění u novorozenců
Článek Terapeutický test s inhibitory protonové pumpy
Článek 24hodinová pH-metrie jícnu
Článek Multikanálová intraluminální impedance kombinovaná s pH-metrií
Článek Úloha ezofagogastroduodenoskopie (EGDS) v diagnostice a terapii refluxního onemocnění
Článek Fibrobronchoskopie v diagnostice refluxního onemocnění
Článek Role endoskopického ORL vyšetření v péči o pacienty s refluxním onemocněním
Článek Role vyšetřovacích metod mimo pH-metrii, MII a endoskopii
Článek Role H2 blokátorů a inhibitorů protonové pumpy v léčbě refluxního onemocnění u dětí
Článek Jiná farmakoterapie (mimo PPI a H2 blokátory)
Článek Nefarmakologická léčba refluxního onemocnění
Článek Editorial
Článek Operační řešení refluxního onemocnění
Článek Refluxní onemocnění u dětí s psychomotorickou retardací (PMR)
Článek Pacienti se zvýšeným rizikem refluxního onemocnění
Článek Diagnostika a léčba refluxního onemocnění u dětí: český sjednocený doporučený postup z pohledu gastroenterologa, pneumologa, ORL lékaře, neonatologa a chirurga
Článek Uvažované gastrointestinální příznaky refluxního onemocnění
Článek Uvažované respirační příznaky refluxního onemocnění
Článek Klinické doporučené postupy v pediatrii v České a Slovenské republice
Článek vyšel v časopise

Česko-slovenská pediatrie

Číslo 1
2016 Číslo 1
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 2/2025 (znalostní test z časopisu)
nový kurz
BONE ACADEMY 2025
Autoři: prof. MUDr. Pavel Horák, CSc., doc. MUDr. Ludmila Brunerová, Ph.D, doc. MUDr. Václav Vyskočil, Ph.D., prim. MUDr. Richard Pikner, Ph.D., MUDr. Olga Růžičková, MUDr. Jan Rosa, prof. MUDr. Vladimír Palička, CSc., Dr.h.c.
Cesta pacienta nejen s SMA do nervosvalového centra
Autoři: MUDr. Jana Junkerová, MUDr. Lenka Juříková
Eozinofilní zánět a remodelace
Autoři: MUDr. Lucie Heribanová
Hypertrofická kardiomyopatie: Moderní přístupy v diagnostice a léčbě
Autoři: doc. MUDr. David Zemánek, Ph.D., MUDr. Anna Chaloupka, Ph.D.
Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#